General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock. | investorplace.com • |
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference | globenewswire.com • |
CytomX Therapeutics Announces New Employment Inducement Grants | globenewswire.com • |
Why Is CytomX (CTMX) Stock Down 43% Today? | investorplace.com • |
CytomX stock down 30% despite encouraging cancer study results | invezz.com • |
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | globenewswire.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-08 | 2024-03 | -0.06 | 0.17 | 0.23 | 383.33% |
2024-03-11 | 2023-12 | 0.02 | 0.01 | -0.01 | -50.00% |
2023-11-07 | 2023-09 | -0.17 | 0.04 | 0.21 | 123.53% |
2023-08-08 | 2023-06 | -0.19 | -0.02 | 0.17 | 89.47% |
2023-05-09 | 2023-03 | -0.16 | -0.05 | 0.11 | 68.75% |
2023-03-27 | 2022-12 | -0.21 | -0.42 | -0.21 | -100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | BMO Capital | Upgrade | Market Perform | Market Perform |
2023-03-27 | Mizuho | Upgrade | Neutral | |
2023-01-05 | BMO Capital | Upgrade | Market Perform | |
2022-11-13 | BMO Capital | Downgrade | Outperform | Market Perform |
2022-11-09 | JP Morgan | Downgrade | Overweight | Underweight |
2022-07-10 | Cowen & Co. | Downgrade | Outperform | Market Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-18 | BELVIN MARCIA | Officer | 168.58K | Sale |
2023-03-15 | CAMPOY CARLOS | Chief Financial Officer | 38.22K | Sale |
2024-01-17 | CHU YU-WAYE | Officer | 26.25K | Stock Award(Grant) |
2022-07-19 | HANNAH ALISON L. | Officer | 31.90K | Sale |
2023-03-28 | JONES ELAINE V | Director | 5.14K | Purchase |
2024-03-18 | LANDAU JEFFREY B | Officer | 117.74K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Tang Capital Management, LLC | 6.60M | 11.35M | 9.89% |
2023-06-29 | BVF Inc. | 6.60M | 11.34M | 9.88% |
2023-06-29 | Vanguard Group Inc | 4.90M | 8.43M | 7.34% |
2023-06-29 | Acadian Asset Management. LLC | 2.65M | 4.56M | 3.97% |
2023-06-29 | Jacobs Levy Equity Management, Inc. | 1.62M | 2.79M | 2.43% |
2023-06-29 | Laurion Capital Management, LP | 1.19M | 2.04M | 1.78% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.18M | 3.75M | 3.27% |
2023-06-29 | Vanguard Extended Market Index Fund | 946.56K | 1.63M | 1.42% |
2023-07-30 | Vanguard Explorer Fund, Inc. | 820.46K | 1.43M | 1.23% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 555.12K | 954.80K | 0.83% |
2023-05-30 | Fidelity Extended Market Index Fund | 319.72K | 546.72K | 0.48% |
2023-06-29 | ETF Opportunities Tr-Formidable ETF | 318.11K | 547.15K | 0.48% |
Going 1.5$ or under in 2 days and soon nasdaq compliance problems
Forget this stock
Under 1,5$ soon company has no future
Soon under 1,5$ until end year there will be no advance in drugs research…probably i will buy it in 2025
1,65$ target
Going under 1,5$
Going 1.3$
Going under 1,6$ in 3 days
Soon under 2$
Fair price is 1,5$
Next week stock 1,5$
Stock is good to buy only in 2025
In 2 days will go 1.7$
Collapsing under 2$
Soon under 2$
Results coming not before end 2025…expect it will come back to 2$ and in end 2025 will recover
Going 1.7$
Tomorrow stock will drop all and will come back under 2$
Friday sell off and stock at 2.5